Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Etoricoxib

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 304Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Arcoxia

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Merck

    Etoricoxib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 258

    2019 Revenue in Millions : 288

    Growth (%) : -10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Organon

    Etoricoxib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 244

    2020 Revenue in Millions : 258

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Organon

    Etoricoxib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 241

    2021 Revenue in Millions : 244

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Organon

    Etoricoxib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 257

    2022 Revenue in Millions : 241

    Growth (%) : 7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Merck & Co

    Etoricoxib

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2015 Revenue in Millions : 519

    2014 Revenue in Millions : 471

    Growth (%) : -9%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Merck & Co

    Etoricoxib

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2014 Revenue in Millions : 7.20%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Merck & Co.

    Etoricoxib

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2016 Revenue in Millions : 450

    2015 Revenue in Millions : 471

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Merck & Co. Inc.

    Etoricoxib

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2017 Revenue in Millions : 363

    2016 Revenue in Millions : 450

    Growth (%) : -19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Merck & Co.

    Etoricoxib

    Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

    Currency : USD

    2018 Revenue in Millions : 335

    2017 Revenue in Millions : 363

    Growth (%) : -8%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Arcoxia

    Etoricoxib

    arrow
    PharmaVenue
    Not Confirmed

    Brand Name : Arcoxia

    U.S.A
    arrow
    PharmaVenue
    Not Confirmed

    Merck

    Etoricoxib

    Main Therapeutic Indication : Immunology

    Currency : USD

    2019 Revenue in Millions : 288

    2018 Revenue in Millions : 335

    Growth (%) : -14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF